Literature DB >> 14486942

Studies on agranulocytosis. IV. Effects of chlorpromazine on nucleic acid synthesis of bone marrow cells in vitro.

A V PISCIOTTA, J KALDAHL.   

Abstract

Entities:  

Keywords:  AGRANULOCYTOSIS/chemistry; BONE MARROW/metabolism; CHLORPROMAZINE/toxicology; NUCLEIC ACIDS/metabolism; NUCLEOSIDES AND NUCLEOTIDES/metabolism

Mesh：

Substances：

Year:  1962        PMID： 14486942

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  [ON THE INCORPORATION OF C-14-LEUCINE INTO RABBIT RETICULOCYTES. II. THE EFFECT OF DRUGS ON THE INCORPORATION OF LEUCINE IN WHOLE CELLS].

Authors:  K MAINZER; E SCHAUMLOEFFEL
Journal:  Klin Wochenschr       Date:  1965-03-15

2.  A drug-specific leuco-agglutinin in a fatal case of agranulocytosis due to chlorpromazine.

Authors:  G C HOFFMAN; J S HEWLETT; F L GARZON
Journal:  J Clin Pathol       Date:  1963-05       Impact factor: 3.411

3.  [Immunohematological observations on drug-induced allergic agranulocytosis].

Authors:  U Mey; G Vogel
Journal:  Blut       Date:  1965-08

Review 4.  Drug-induced agranulocytosis.

Authors:  V Pisciotta
Journal:  Drugs       Date:  1978-02       Impact factor: 9.546

5.  Agranulocytosis associated with semisynthetic penicillins and cephalosporins. Report of 7 cases.

Authors:  L Schmid; W Heit; R Flury
Journal:  Blut       Date:  1984-01

Review 6.  Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance.

Authors:  W N Patton; S B Duffull
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

7.  Agranulocytosis: a report of 30 cases.

Authors:  H M Pretty; G Gosselin; G Colpron; L A Long
Journal:  Can Med Assoc J       Date:  1965-11-13       Impact factor: 8.262

8.  Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment.

Authors:  Pareesa Kamgar-Dayhoff; Tinatin I Brelidze
Journal:  Oncotarget       Date:  2021-07-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.